Jerzy Gumulka - Net Worth and Insider Trading

Jerzy Gumulka Net Worth

The estimated net worth of Jerzy Gumulka is at least $8,412 dollars as of 2024-05-11. Jerzy Gumulka is the Director of CNS Pharmaceuticals Inc and owns about 43,006 shares of CNS Pharmaceuticals Inc (CNSP) stock worth over $8,412. Details can be seen in Jerzy Gumulka's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jerzy Gumulka has not made any transactions after 2024-02-01 and currently still holds the listed stock(s).

Transaction Summary of Jerzy Gumulka

To

Jerzy Gumulka Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jerzy Gumulka owns 1 companies in total, including CNS Pharmaceuticals Inc (CNSP) .

Click here to see the complete history of Jerzy Gumulka’s form 4 insider trades.

Insider Ownership Summary of Jerzy Gumulka

Ticker Comapny Transaction Date Type of Owner
CNSP CNS Pharmaceuticals Inc 2024-02-01 director

Jerzy Gumulka Latest Holdings Summary

Jerzy Gumulka currently owns a total of 1 stock. Jerzy Gumulka owns 43,006 shares of CNS Pharmaceuticals Inc (CNSP) as of February 1, 2024, with a value of $8,412.

Latest Holdings of Jerzy Gumulka

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNSP CNS Pharmaceuticals Inc 2024-02-01 43,006 0.20 8,412

Holding Weightings of Jerzy Gumulka


Jerzy Gumulka Form 4 Trading Tracker

According to the SEC Form 4 filings, Jerzy Gumulka has made a total of 3 transactions in CNS Pharmaceuticals Inc (CNSP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in CNS Pharmaceuticals Inc is the acquisition of 33,333 shares on February 1, 2024, which cost Jerzy Gumulka around $10,000.

Insider Trading History of Jerzy Gumulka

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jerzy Gumulka Trading Performance

GuruFocus tracks the stock performance after each of Jerzy Gumulka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jerzy Gumulka is 77.76%. GuruFocus also compares Jerzy Gumulka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jerzy Gumulka within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jerzy Gumulka's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jerzy Gumulka

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 41.61
Relative Return to S&P 500(%) 39.51

Jerzy Gumulka Ownership Network

Ownership Network List of Jerzy Gumulka

No Data

Ownership Network Relation of Jerzy Gumulka


Jerzy Gumulka Owned Company Details

What does CNS Pharmaceuticals Inc do?

Who are the key executives at CNS Pharmaceuticals Inc?

Jerzy Gumulka is the director of CNS Pharmaceuticals Inc. Other key executives at CNS Pharmaceuticals Inc include Chief Financial Officer Christopher Downs , director & Chief Executive Officer John M Climaco , and 10 percent owner Waldemar Priebe .

CNS Pharmaceuticals Inc (CNSP) Insider Trades Summary

Over the past 18 months, Jerzy Gumulka made 3 insider transaction in CNS Pharmaceuticals Inc (CNSP) with a net purchase of 43,006. Other recent insider transactions involving CNS Pharmaceuticals Inc (CNSP) include a net purchase of 184,416 shares made by John M Climaco , a net purchase of 96,766 shares made by Christopher Downs , and a net sale of 94,298 shares made by Waldemar Priebe .

In summary, during the past 3 months, insiders sold 0 shares of CNS Pharmaceuticals Inc (CNSP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 94,298 shares of CNS Pharmaceuticals Inc (CNSP) were sold and 357,521 shares were bought by its insiders, resulting in a net purchase of 263,223 shares.

CNS Pharmaceuticals Inc (CNSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CNS Pharmaceuticals Inc Insider Transactions

No Available Data

Jerzy Gumulka Mailing Address

Above is the net worth, insider trading, and ownership report for Jerzy Gumulka. You might contact Jerzy Gumulka via mailing address: C/o Cns Pharmaceuticals, Inc., 2100 West Loop South Ste 900, Houston Tx 77027.

Discussions on Jerzy Gumulka

No discussions yet.